Category: NxStage Medical Inc.Syndicate content

Shockwave Medical raises $40 million for its 'lithoplasty' system | Medtech funding for the week of May 18, 2015

May 22, 2015 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: PAD: Shockwave Medical raises $40M; PAD: Intact Vascular raises $39m for Tack device; ConvaTec plans $1.9B refi; Outset Medical raises $60m for home dialysis device; Smith & Nephew gets in on OrthoSpace round

PAD: Shockwave Medical raises $40M

May 19, 2015 by Fink Densford

PAD: Shockwave Medical raises $40M

Outset Medical raises $60m for home dialysis device

May 20, 2015 by Fink Densford

Home hemodialysis device developer Outset Medical raises $60 million for its Tablo dialysis system.

Outset Medical raises $60m for home dialysis device

NxStage gains on Q4, 2014 beats, opens Boston dialysis centers

February 26, 2015 by Brad Perriello

NxStage Medical beats expectations with its 4th-quarter and full-year results and opens 2 new dialysis centers in the Boston area, sending share prices up today.

NxStage gains on Q4, 2014 beats, opens Boston dialysis centers

ExThera joins DARPA sepsis project

January 12, 2015 by Mark Hollmer

ExThera Medical joins NxStage Medical and Battelle on a project with the Pentagon's DARPA arm to develop a medical device to treat sepsis.

ExThera joins DARPA sepsis project

ExThera Medical signed on to a multi-company U.S. Defense Dept. contract focused on developing a medical device to treat sepsis. The California company's main contribution: A 2nd-generation version of its Seraph blood-filtering tech.

NxStage Medical wins FDA nod for nocturnal home dialysis

December 22, 2014 by Brad Perriello

NxStage Medical says it won 510(k) clearance from the FDA for nocturnal home hemodialysis treatments using its System One device.

NxStage Medical wins FDA nod for nocturnal homedialysis

Pulmonx taps ex-Asthmatx CEO French for the corner office | Personnel Moves

December 19, 2014 by Brad Perriello

Pulmonx taps former Asthmatx CEO Glen French to be its new chief executive.

Pulmonx taps ex-Asthmatx CEO French for the corner office | Personnel Moves

Pulmonx said yesterday that it named Glen French, the co-founder and CEO of Asthmatx who led it to an acquisition by BSX, to be its new president and chief executive.